Continuous renal replacement therapy (CRRT) in patients with liver disease: Is circuit life different?
Authors:
- Banwari AgarwalBABanwari Agarwal
- Steve ShawSSSteve Shaw
- Manu Shankar HariMHManu Shankar Hari
- Andrew K. BurroughsABAndrew K. Burroughs
- Andrew DavenportADAndrew Davenport
- 1 September 2009
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 51 (3) , 504-509
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The Effect of Vascular Access Location and Size on Circuit Survival in Pediatric Continuous Renal Replacement Therapy: A Report from the PPCRRT RegistryThe International Journal of Artificial Organs, 2007
- Continuous renal replacement therapy: A worldwide practice surveyIntensive Care Medicine, 2007
- Abnormal hemostasis tests and bleeding in chronic liver disease: are they related? YesJournal of Thrombosis and Haemostasis, 2006
- A Practical Citrate Anticoagulation Continuous Venovenous Hemodiafiltration Protocol for Metabolic Control and High Solute ClearanceClinical Journal of the American Society of Nephrology, 2006
- Acute Renal Failure and SepsisNew England Journal of Medicine, 2004
- The Acute Dialysis Quality Initiative—Part VI: Access and anticoagulation in CRRTAdvances in Renal Replacement Therapy, 2002
- Derangements of Coagulation and Fibrinolysis in Critically III Patients with Sepsis and Septic ShockSeminars in Thrombosis and Hemostasis, 1998
- Anticoagulation in Patients Treated by Continuous Venovenous Hemofiltration: A Retrospective StudyAmerican Journal of Kidney Diseases, 1994
- Comparison of the Use of Standard Heparin and Prostacyclin Anticoagulation in Spontaneous and Pump-Driven Extracorporeal Circuits in Patients with Combined Acute Renal and Hepatic FailureNephron, 1994
- Anticoagulant regimens in acute continuous hemodiafiltration: a comparative studyIntensive Care Medicine, 1993